Literature DB >> 30948377

Assessing Vascularity of Osseous Spinal Metastases with Dual-Energy CT-DSA: A Pilot Study Compared with Catheter Angiography.

Y-C Huang1, F-Y Tsuang2, C-W Lee1, C-Y Wu3, Y-H Lin4.   

Abstract

BACKGROUND AND
PURPOSE: Spine debulking surgery in patients with hypervascular spinal metastasis is associated with massive intraoperative blood loss, but currently, the vascularity of tumor is determined by invasive conventional angiography or dynamic contrast MR imaging. We aimed to investigate the usefulness of noninvasive dual-energy CT-DSA, comparing it with conventional angiography in evaluating the vascularity of spinal metastasis.
MATERIALS AND METHODS: We conducted a retrospective study from January to December 2018. A total of 15 patients with spinal metastasis undergoing dual-energy CT, conventional DSA, and subsequent debulking surgery were included. CT-DSA images were produced after rigid-body registration and subtraction between CT phases. Qualitative and quantitative assessments of tumor vascularity were conducted. Correlations between CT-DSA and conventional DSA results were evaluated using the Spearman coefficient. The mean enhancement in the estimated tumor volume and surgical blood loss was compared between hypervascular and nonhypervascular groups using the Wilcoxon rank sum test.
RESULTS: The CT-DSA and DSA results were strongly correlated, with ρ = 0.87 (P < .001). The DSA and the quantitative enhancement index also showed a strong correlation with ρ = 0.83 (P < .001). Wilcoxon rank sum testing between hypervascular and nonhypervascular CT-DSA groups showed a difference in enhancement indices (P = .0003). The blood loss between the hypervascular and nonhypervascular groups was nonsignificant (P = .09).
CONCLUSIONS: Dual-energy CT-DSA correlates well with conventional DSA in assessing the vascularity of spinal metastasis. It may serve as a noninvasive preoperative evaluation option before debulking surgery.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2019        PMID: 30948377      PMCID: PMC7053889          DOI: 10.3174/ajnr.A6023

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  39 in total

1.  Does preoperative transarterial embolization decrease blood loss during spine tumor surgery?

Authors:  Zhihong Qiao; Ningyang Jia; Qian He
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

Review 2.  Technical limitations of dual-energy CT in neuroradiology: 30-month institutional experience and review of literature.

Authors:  Julien Dinkel; Omid Khalilzadeh; Catherine M Phan; Ajit H Goenka; Albert J Yoo; Joshua A Hirsch; Rajiv Gupta
Journal:  J Neurointerv Surg       Date:  2014-06-20       Impact factor: 5.836

3.  A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis.

Authors:  Yasuaki Tokuhashi; Hiromi Matsuzaki; Hiroshi Oda; Masashi Oshima; Junnosuke Ryu
Journal:  Spine (Phila Pa 1976)       Date:  2005-10-01       Impact factor: 3.468

Review 4.  Musculoskeletal wide detector CT: principles, techniques and applications in clinical practice and research.

Authors:  Pedro Augusto Gondim Teixeira; Alban Gervaise; Matthias Louis; Sophie Lecocq; Ariane Raymond; Sabine Aptel; Alain Blum
Journal:  Eur J Radiol       Date:  2015-01-17       Impact factor: 3.528

5.  Australian diagnostic reference levels for multi detector computed tomography.

Authors:  Anna Hayton; Anthony Wallace; Paul Marks; Keith Edmonds; David Tingey; Peter Johnston
Journal:  Australas Phys Eng Sci Med       Date:  2013-01-11       Impact factor: 1.430

6.  A Flexible Method for Multi-Material Decomposition of Dual-Energy CT Images.

Authors:  Paulo R S Mendonca; Peter Lamb; Dushyant V Sahani
Journal:  IEEE Trans Med Imaging       Date:  2013-09-16       Impact factor: 10.048

7.  Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.

Authors:  Atin Saha; Kyung K Peck; Eric Lis; Andrei I Holodny; Yoshiya Yamada; Sasan Karimi
Journal:  Spine (Phila Pa 1976)       Date:  2014-11-15       Impact factor: 3.468

8.  Epidural spinal cord compression from metastatic tumor: diagnosis and treatment.

Authors:  R W Gilbert; J H Kim; J B Posner
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

9.  Bone-Subtracted Spinal CT Angiography Using Nonrigid Registration for Better Visualization of Arterial Feeders in Spinal Arteriovenous Fistulas.

Authors:  T Nishii; A K Kono; M Nishio; N Negi; A Fujita; E Kohmura; K Sugimura
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

10.  Spinal metastasis: a retrospective study validating the treatment algorithm.

Authors:  M Cappuccio; A Gasbarrini; P Van Urk; S Bandiera; S Boriani
Journal:  Eur Rev Med Pharmacol Sci       Date:  2008 May-Jun       Impact factor: 3.507

View more
  4 in total

1.  Freehand Minimally Invasive Pedicle Screw Fixation and Minimally Invasive Decompression for a Thoracic or Lumbar Vertebral Metastatic Tumor From Hepatocellular Carcinoma.

Authors:  Wenshuai Fan; Tianyao Zhou; Jinghuan Li; Yunfan Sun; Yutong Gu
Journal:  Front Surg       Date:  2021-12-01

2.  Spontaneous closure of an incidental high-flow paravertebral arteriovenous fistula caused by vertebral giant cell tumor curettage: illustrative case.

Authors:  Yen-Heng Lin; Yu-Cheng Huang; Fon-Yih Tsuang
Journal:  J Neurosurg Case Lessons       Date:  2021-05-03

3.  Primary intraosseous meningioma of the vertebra: illustrative case.

Authors:  Ue-Cheung Ho; Koping Chang; Yen-Heng Lin; Yu-Cheng Huang; Fon-Yih Tsuang
Journal:  J Neurosurg Case Lessons       Date:  2021-10-18

4.  Subtraction iodine imaging with area detector CT to improve tumor delineation and measurability of tumor size and depth of invasion in tongue squamous cell carcinoma.

Authors:  Takashi Hiyama; Hirofumi Kuno; Kotaro Sekiya; So Tsushima; Shioto Oda; Tatsushi Kobayashi
Journal:  Jpn J Radiol       Date:  2021-09-16       Impact factor: 2.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.